Related Experiment Videos
[Ischaemic heart disease in cancer patients. Questions and problems]
Petra Gulácsi-Bárdos1,2, Miklós Szokol3, Mária Lódi4
1Cardiovascularis Centrum, Uzsoki Utcai Kórház Budapest.
Orvosi Hetilap
|November 15, 2017
Summary
Cardiovascular and oncologic diseases significantly increase mortality. Cardio-oncology addresses the growing need for specialized cardiovascular care in cancer patients, improving survival rates.
Area of Science:
- Cardiology
- Oncology
- Cardio-Oncology
Background:
- Cardiovascular and oncologic diseases cause over 50% of European mortality.
- Cancer therapies increase the risk of acute coronary syndrome by 2- to 7-fold.
- Limited data exists on cardiovascular treatment for cancer patients due to exclusion from studies.
Purpose of the Study:
- To review current challenges and treatments for cancer patients with ischemic heart disease.
- To highlight the growing importance of cardio-oncology.
- To provide guidance based on recent guidelines and studies.
Main Methods:
- Review of recent guidelines.
- Analysis of published studies.
- Examination of local treatment protocols.
Main Results:
- Cardio-oncology is a recognized specialty by major cardiology societies.
- New cancer treatments are increasing the number of cancer survivors.
- There is a lack of clear protocols for managing cardiovascular issues in cancer patients.
Conclusions:
- Cardio-oncology is crucial for managing the cardiovascular health of a growing cancer survivor population.
- Standardized treatment protocols are needed for oncologic patients with ischemic heart disease.
- This review synthesizes current knowledge to guide clinical practice.